The nasal spray is now undergoing phase three ... In the UK, doctors have been trialling ketamine to treat depression since 2011. Dr Rupert McShane, who has led a trial in Oxford, says ketamine ...
A nasal spray containing mind-altering “party drug” ketamine had a fast-acting effect on reducing the symptoms of severe depression, including suicidal thoughts, in a study carried out in the US.
However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button. Objectives: Intravenous ketamine (IVK) and intranasal esketamine (ESK) are increasingly used in ...
It’s a significant finding because, to date, most studies of ketamine in depression have relied on either intravenous or intranasal administration, the latter resulting in the approval of J&J ...
BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...
A watershed moment came in March when the U.S. Food and Drug Administration (FDA) approved Spravato, or esketamine, a ketamine nasal spray for adults with treatment-resistant major depression.
Attempts to use intranasal racemic ketamine for suicidal depression have failed. The Company has formed data-sharing partnerships to license clinical trial data from a French Government-funded ...